KASANDRA KEESLAR: Open Payments
NPI 1568122463 · PIKEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 33 payments from 11 companies in 2025. Trend: 2023 $218 · 2024 $538 · 2025 $667
Food & beverage: $590Education: $77
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 10 | $173 |
| Sumitomo Pharma America, Inc. | 7 | $107 |
| Astellas Pharma US Inc | 2 | $99 |
| Exeltis, USA Inc. | 4 | $68 |
| SHIELD THERAPEUTICS INC | 1 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: ZURZUVAE, MYFEMBREE, SLYND, ACCRUFER, Exparel, Qelbree, Dexcom G6 Transmitter, Veozah.
Industry payments across KY — which companies pay providers there.
